Correlation Between Stayble Therapeutics and Sprint Bioscience

Can any of the company-specific risk be diversified away by investing in both Stayble Therapeutics and Sprint Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stayble Therapeutics and Sprint Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stayble Therapeutics AB and Sprint Bioscience AB, you can compare the effects of market volatilities on Stayble Therapeutics and Sprint Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stayble Therapeutics with a short position of Sprint Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stayble Therapeutics and Sprint Bioscience.

Diversification Opportunities for Stayble Therapeutics and Sprint Bioscience

0.34

Correlation Coefficient

Stayble Therapeutics  Sprint Bioscience

Weak diversification

The 3 months correlation between Stayble and Sprint is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Stayble Therapeutics AB and Sprint Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprint Bioscience and Stayble Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stayble Therapeutics AB are associated (or correlated) with Sprint Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint Bioscience has no effect on the direction of Stayble Therapeutics i.e., Stayble Therapeutics and Sprint Bioscience go up and down completely randomly.

Pair Corralation between Stayble Therapeutics and Sprint Bioscience

Assuming the 90 days trading horizon Stayble Therapeutics AB is expected to generate 1.12 times more return on investment than Sprint Bioscience. However, Stayble Therapeutics is 1.12 times more volatile than Sprint Bioscience AB. It trades about 0.02 of its potential returns per unit of risk. Sprint Bioscience AB is currently generating about -0.03 per unit of risk. If you would invest  45.00  in Stayble Therapeutics AB on April 24, 2025 and sell it today you would lose (2.00) from holding Stayble Therapeutics AB or give up 4.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Stayble Therapeutics AB  vs.  Sprint Bioscience AB

Stayble Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Stayble Therapeutics AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Stayble Therapeutics may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Sprint Bioscience

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sprint Bioscience AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Stayble Therapeutics and Sprint Bioscience

The main advantage of trading using opposite Stayble Therapeutics and Sprint Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stayble Therapeutics position performs unexpectedly, Sprint Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprint Bioscience will offset losses from the drop in Sprint Bioscience's long position.

The idea behind Stayble Therapeutics AB and Sprint Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..